Upon examination of paired serum and synovial fluid samples from PsA patients, higher levels were seen in the synovial fluid in comparison to the blood; this indicates that CXCL10 may be a biomarker for the development of PsA in patients suffering from psoriasis and could be pathogenetically involved in its development35. Here, CXCL10 is linked to psoriasis.